Contraportada - AMVAC

Bibliografía
SEROCONVERSIÓN PERMANENTE EN UN GATO CON PIF - NOVO, L y SANjURjO, Mª j.
• Weiss, R.C., Cox, N.R., Oostrom-Ram, T., 1990. Effect of interferon or Propionibacterium acnes on the course of experimentally indu-
ced feline infectious peritonitis in specific-pathogen free and random-source cats. Am. J. Vet. Res. 51, 726–733.
• Novo Fernández, L., Sanjurjo Martínez, MJ. Peritonitis infecciosa felina. Diagnóstico y evolución de cinco casos clínicos. Proceeding
IV encontros veterinarios galegos y I encontros veterinarios galaico-portugueses. 1999;361-64.
• Ritz, S.J., Egberink, H., Hartmann, K., 2007. Influence of feline interferon-omega on the survival time and quality of life of cats with
feline infectious peritonitis. J. Vet. Intern. Med. 21, 1193–1197.
• Barlough, J.E., Scott, F.W., 1990. Effectiveness of three antiviral agents against FIP virus in vitro. Vet. Rec. 126, 556–558.
• Hartmann, K., 2006. Feline infectious peritonitis: new aspects of diagnosis and treatment. In: Proceedings of the 24th Annual ACVIM
(American College of Veterinary Internal Medicine) Forum, Louisville, USA, pp. 591–593.
• Ford, R.B., 1986. Biological response modifiers in the management of viral infections. Vet. Clin. North Am. Small Anim. Pract.
16,1191–1204.
• Ishida, T., Shibanai, A., Tanaka, S., Uchida, K., Mochizuki, M., 2004.Use of recombinant feline interferon and glucocorticoid in the
treatment of feline infectious peritonitis. J. Feline Med. Surg. 6, 107–109.
• Pedersen NC, Meric SM, Ho E, Johnson L, Plucker S, Theilen GH. The clinical significance of latent feline leukemia virus infection in
cats. Feline Pract 1984; 14: 32e48.
• Wright, KN.,Gompf, RE., DeNovo, RC jr. Peritoneal effusion in cats: 65 cases (1981 – 1997) in JAVMA vol 214, nº 3. Feb, 1999. 375 -381
• Addie DD, Toth S, Murray GD, Jarrett O. Risk of feline infectious peritonitis in cats naturally infected with
• feline coronavirus. Am J Vet Res 1995; 56: 429e34.
• Foley JE, Poland A, Carlson J, Pedersen NC. Risk factors for feline infectious peritonitis among cats in multiple-
• cat environments with endemic feline enteric coronavirus. J Am Vet Med Assoc 1997; 210: 1313e8.
• Wright KN, Gompf RE, DeNovo Jr RC. Peritoneal effusion in cats: 65 cases (1981e1997). J Am Vet Med Assoc
• 1999; 214: 375e81.
• Toomey JM, Carlisle-Nowak MM, Barr SC, et al. Concurrent toxoplasmosis and feline infectious peritonitis
• in a cat. J Am Anim Hosp Assoc 1995; 31: 425e58.
• Gerber JD, Ingersoll JD, Gast AM, et al. Protection against feline infectious peritonitis by intranasal inoculation
• of a temperature-sensitive FIPV vaccine. Vaccine 1990; 8: 536e42.
• Postorino-Reeves N, Coyne MJ, Herman JG. Evaluation of the field efficacy of Primucell-FIP vaccine. Feline
• Health Top 1992; 7: 6e8.
• Reeves NC, Pollock RV, Thurber ET. Long-term followup study of cats vaccinated with a temperaturesensitive
• feline infectious peritonitis vaccine. Cornell Vet 1992; 82: 117e23.
• Hoskins JD, Taylor HW, Lomax TL. Challenge trial of an intranasal feline infectious peritonitis vaccine. Feline
• Pract 1994; 22: 9e13.
• Kass PH, Dent TH. The epidemiology of feline infectious peritonitis. Feline Pract 1995; 23: 27–32.
• Barloug, JE.,Stoddart, CA. Feline coronaviral infections, en Green, CE (ed): infectious diseases of the dog and cat. Philadelphia, WB
Saunders Co, 1990
• Diaz Sacristan, J. Peritonitis infecciosa felina: aproximacion al diagnóstico. En Pequeños animales. Nov. 1996
• Wolf, AM. FIP update: what´s new, what´s not, what´s hot. In scientific presentations of the 64TH anual meeting. San Diego, CA.
AAHA, 1997. 79-84
11